Can NPT be used to distinguish eosinophilic inflammatory phenotypes in COPD?
Near-patient testing (NPT) is increasingly being used in the management of chronic conditions. In COPD, NPT devices include the spirometer and saturation probe, but these do not directly guide treatment. The blood eosinophil count at a cut off of ≥2% has been shown to determine which patients should...
| Váldodahkkit: | , , , |
|---|---|
| Materiálatiipa: | Conference item |
| Almmustuhtton: |
European Respiratory Society
2016
|
| _version_ | 1826283701571420160 |
|---|---|
| author | Hambleton, K Borg, C Connolly, C Bafadhel, M |
| author_facet | Hambleton, K Borg, C Connolly, C Bafadhel, M |
| author_sort | Hambleton, K |
| collection | OXFORD |
| description | Near-patient testing (NPT) is increasingly being used in the management of chronic conditions. In COPD, NPT devices include the spirometer and saturation probe, but these do not directly guide treatment. The blood eosinophil count at a cut off of ≥2% has been shown to determine which patients should receive corticosteroids for exacerbations. An NPT that accurately correlates with whole blood eosinophil counts would be useful. |
| first_indexed | 2024-03-07T01:02:51Z |
| format | Conference item |
| id | oxford-uuid:8a4d851d-0af0-47f7-a4ea-2c2658040bf5 |
| institution | University of Oxford |
| last_indexed | 2024-03-07T01:02:51Z |
| publishDate | 2016 |
| publisher | European Respiratory Society |
| record_format | dspace |
| spelling | oxford-uuid:8a4d851d-0af0-47f7-a4ea-2c2658040bf52022-03-26T22:30:43ZCan NPT be used to distinguish eosinophilic inflammatory phenotypes in COPD?Conference itemhttp://purl.org/coar/resource_type/c_5794uuid:8a4d851d-0af0-47f7-a4ea-2c2658040bf5Symplectic Elements at OxfordEuropean Respiratory Society2016Hambleton, KBorg, CConnolly, CBafadhel, MNear-patient testing (NPT) is increasingly being used in the management of chronic conditions. In COPD, NPT devices include the spirometer and saturation probe, but these do not directly guide treatment. The blood eosinophil count at a cut off of ≥2% has been shown to determine which patients should receive corticosteroids for exacerbations. An NPT that accurately correlates with whole blood eosinophil counts would be useful. |
| spellingShingle | Hambleton, K Borg, C Connolly, C Bafadhel, M Can NPT be used to distinguish eosinophilic inflammatory phenotypes in COPD? |
| title | Can NPT be used to distinguish eosinophilic inflammatory phenotypes in COPD? |
| title_full | Can NPT be used to distinguish eosinophilic inflammatory phenotypes in COPD? |
| title_fullStr | Can NPT be used to distinguish eosinophilic inflammatory phenotypes in COPD? |
| title_full_unstemmed | Can NPT be used to distinguish eosinophilic inflammatory phenotypes in COPD? |
| title_short | Can NPT be used to distinguish eosinophilic inflammatory phenotypes in COPD? |
| title_sort | can npt be used to distinguish eosinophilic inflammatory phenotypes in copd |
| work_keys_str_mv | AT hambletonk cannptbeusedtodistinguisheosinophilicinflammatoryphenotypesincopd AT borgc cannptbeusedtodistinguisheosinophilicinflammatoryphenotypesincopd AT connollyc cannptbeusedtodistinguisheosinophilicinflammatoryphenotypesincopd AT bafadhelm cannptbeusedtodistinguisheosinophilicinflammatoryphenotypesincopd |